Allarity Therapeutics, Inc.
General ticker "ALLR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $17.1M (TTM average)
Allarity Therapeutics, Inc. follows the US Stock Market performance with the rate: 30.5%.
Estimated limits based on current volatility of 6.7%: low 1.45$, high 1.66$
Factors to consider:
- Total employees count: 9 (-30.8%) as of 2022
- Top business risk factors: Economic downturns and volatility, Regulatory and compliance, Supply chain disruptions, Clinical development risks, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.75$, 2.84$]
- 2026-12-31 to 2027-12-31 estimated range: [0.50$, 1.99$]
Financial Metrics affecting the ALLR estimates:
- Positive: with PPE of -1.3 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of -99.48 <= 0.02
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of -0.05 > -0.63
- Positive: 42.58 < Shareholder equity ratio, % of 53.83 <= 64.15
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term ALLR quotes
Long-term ALLR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.32MM |
| Operating Expenses | $17.13MM | $27.24MM | $12.93MM |
| Operating Income | $-17.13MM | $-27.24MM | $-12.61MM |
| Non-Operating Income | $5.31MM | $2.35MM | $1.37MM |
| Interest Expense | $0.50MM | $0.65MM | $0.18MM |
| R&D Expense | $7.10MM | $6.10MM | $6.60MM |
| Income(Loss) | $-11.82MM | $-24.90MM | $-11.23MM |
| Taxes | $0.08MM | $-0.38MM | $0.00MM |
| Profit(Loss)* | $-11.90MM | $-24.52MM | $-22.46MM |
| Stockholders Equity | $-2.75MM | $11.81MM | $9.83MM |
| Assets | $11.86MM | $22.65MM | $18.26MM |
| Operating Cash Flow | $-12.74MM | $-17.35MM | $-14.82MM |
| Capital expenditure | $0.00MM | $0.30MM | $0.01MM |
| Investing Cash Flow | $0.00MM | $-0.30MM | $-0.01MM |
| Financing Cash Flow | $10.99MM | $36.79MM | $10.65MM |
| Earnings Per Share** | $-3.59 | $-15.26 | $-1.56 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.